Pharmacologic management of cancer pain in rural Minnesota

Journal of Pain and Symptom Management
L LichtblauT E Elliott

Abstract

Use of analgesic medications for cancer pain was assessed in six Minnesota communities. In our survey, cancer patients were treated primarily by family practice physicians. Approximately 70% were given one or more analgesics; 84% received a nonsteroidal antiinflammatory drug and 73% received an opioid. Most patients given an antiinflammatory drug received less than the maximal recommended dose for the drug. The most common opioid for cancer pain was oral morphine. Approximately 40% of the patients treated with opioids took the drug only when needed; the remainder took the drug around-the-clock, with or without additional opioids for breakthrough pain. Only 14% of patients who received analgesics received a coanalgesic and only 13% received a nonanalgesic adjuvant. The patterns of analgesic use in these communities corresponded well with accepted principles of cancer pain management: liberal use of opioids, use of oral morphine as the predominant agent, and avoidance of meperidine and opioid agonist/ antagonists.

References

Jun 13, 1992·Lancet·K Lote
Oct 1, 1990·Current Opinion in Oncology·S A Grossman
Jan 1, 1986·Journal of Chronic Diseases·R J GoldbergJ Hiris
Jul 11, 1985·The New England Journal of Medicine·K M Foley
Jan 1, 1987·Journal of Pain and Symptom Management·E BrueraN MacDonald
Feb 1, 1983·Annals of Neurology·R F KaikoM M Reidenberg
Mar 3, 1994·The New England Journal of Medicine·A JacoxR Payne
Sep 30, 1994·Science·M S BoguskiD E Bassett

❮ Previous
Next ❯

Citations

Aug 1, 1996·Journal of Pain and Symptom Management·W Z SunJ H Li
Apr 1, 1997·Journal of Pain and Symptom Management·T E ElliottJ Post-White
Jul 13, 1999·Journal of Clinical Nursing·R NashR Clark
May 25, 2002·Cancer Practice·Tammy E BalticGilbert Fanciullo
Oct 9, 2008·Journal of Nursing Scholarship : an Official Publication of Sigma Theta Tau International Honor Society of Nursing·Anne H SkellyDorothy Burns
Nov 15, 2014·Neuromodulation : Journal of the International Neuromodulation Society·Timothy DeerRobert Levy
Apr 30, 2002·The Annals of Pharmacotherapy·Margaret A CordingRheta Sandoval

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Pharmacy and Therapeutics
F M Hull
Annals of Emergency Medicine
R M Williams
Journal of Pain and Symptom Management
D E Weissman, J L Dahl
The American Journal of Hospice & Palliative Care
S Chandler, R Payne
© 2021 Meta ULC. All rights reserved